alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 60, Number 103 (Tuesday, May 30, 1995)]
[Notices]
[Page 28159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-13122]



-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Advisory Committee to the Director, Centers for Disease Control 
and Prevention; Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Advisory Committee to the Director, CDC.
    Time and Date: 8:30 a.m.-3 p.m., June 23, 1995.
    Place: CDC, Auditorium A, 1600 Clifton Road, NE, Atlanta, 
Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: This committee advises the Director, CDC, on policy 
issues and broad strategies that will enable CDC, the Nation's 
prevention agency, to fulfill its mission of promoting health and 
quality of life by preventing and controlling disease, injury, and 
disability. The committee recommends ways to incorporate prevention 
activities more fully into health care. It also provides guidance to 
help CDC work more effectively with its various constituents, in 
both the private and public sectors, to make prevention a practical 
reality.
    Matters To Be Discussed: The agenda will include updates from 
CDC Director, David Satcher, M.D., Ph.D., followed by committee 
discussion on CDC's evolving relationship with managed care and 
major challenges to public health science and to CDC programs.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Martha F. Katz, Executive 
Secretary, Advisory Committee to the Director, CDC, 1600 Clifton 
Road, NE, Mailstop D-23, Atlanta, Georgia 30333, telephone 404/639-
3243.

    Dated: May 23, 1995.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 95-13122 Filed 5-26-95; 8:45 am]
BILLING CODE 4163-18-M
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
|----|-----------------------------------------------------------------------------------------------------------------------------------|

| 2.     | The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company. |
|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |                                                                                                                                                  |

|           | Company Name |                                                                                                                      |
|----------------|--------------|---------------------------------------------------------------------------------------------------------------------------|
|           |         |                                                                                                                      |   |
| March 24, 2011 | By:          | /s/ Wallace Boyack                                                                                                   |   |
|           |         | Wallace Boyack                                                                                                            |   |
|           |         | Chief Executive Officer, Chief Financial Officer, principal executive officer, principal financial and accounting officer |   |
|           |         |                                                                                                                      |   |
---

March 29, 2011VIA EDGAR United States
Securities and Exchange Commission

|Re: | Northern Dynasty Minerals Ltd. (the "Company")
|--- | ----------------------------------------------
|    |                                               
|    | Annual Report on Form 40-F                    
|    |                                               
|    | Consent of Expert                             

This letter is provided in connection with the Company's Form
40-F annual report for the year ended December 31, 2010, (the Annual Report)
to be filed by the Company with the United States Securities and Exchange
Commission (the SEC).

I, Robert Morrison, P.Geo, hereby consent to the use of my name
in connection with reference to my involvement in the preparation of the
following technical report (the "Technical Report"):

- Preliminary Assessment of the Pebble Project, Southwest Alaska dated
  February 17, 2011

and to references to the Technical Report, or portions thereof,
in the Annual Report and to the inclusion and incorporation by reference of the
information derived from the Technical Reports in the Annual Report.

I have read the Companys Annual Report and confirm that it
documents fairly and accurately represent the information that supports the
disclosure.

Yours truly,



/s/ Robert Morrison

---

Robert Morrison, P.Geo

Wardrop Engineering Inc.

---
V 

109TH CONGRESS 

1ST SESSION H. R. 1867 

For the relief of Mohammed Manir Hossain, Ferdous Ara Manir, and Maish 

Samiha Manir. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 26, 2005 

Mr. ANDREWS introduced the following bill; which was referred to the 

Committee on the Judiciary 

A BILL 

For the relief of Mohammed Manir Hossain, Ferdous Ara 

Manir, and Maish Samiha Manir. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PERMANENT RESIDENT STATUS FOR MOHAM4 MED MANIR HOSSAIN, FERDOUS ARA MANIR, 

5 AND MAISH SAMIHA MANIR. 

6 (a) IN GENERAL.—Notwithstanding subsections (a) 

7 and (b) of section 201 of the Immigration and Nationality 

8 Act, Mohammed Manir Hossain, Ferdous Ara Manir, and 

9 Maish Samiha Manir shall each be eligible for issuance 

10 of an immigrant visa or for adjustment of status to that 
2 

•HR 1867 IH 

1 of an alien lawfully admitted for permanent residence 

2 upon filing an application for issuance of an immigrant 

3 visa under section 204 of such Act or for adjustment of 

4 status to lawful permanent resident. 

5 (b) ADJUSTMENT OF STATUS.—If Mohammed Manir 

6 Hossain, Ferdous Ara Manir, or Maish Samiha Manir en7 ters the United States before the filing deadline specified 

8 in subsection (c), he or she shall be considered to have 

9 entered and remained lawfully and shall, if otherwise eligi10 ble, be eligible for adjustment of status under section 245 

11 of the Immigration and Nationality Act as of the date of 

12 the enactment of this Act. 

13 (c) DEADLINE FOR APPLICATION AND PAYMENT OF

14 FEES.—Subsections (a) and (b) shall apply only if the ap15 plication for issuance of an immigrant visa or the applica16 tion for adjustment of status is filed with appropriate fees 

17 within 2 years after the date of the enactment of this Act. 

18 (d) REDUCTION OF IMMIGRANT VISA NUMBER.— 

19 Upon the granting of an immigrant visa or permanent res20 idence to Mohammed Manir Hossain, Ferdous Ara Manir, 

21 and Maish Samiha Manir, the Secretary of State shall in22 struct the proper officer to reduce by 3, during the current 

23 or next following fiscal year, the total number of immi24 grant visas that are made available to natives of the coun25 try of the aliens’ birth under section 203(a) of the Immi-
3 

•HR 1867 IH 

1 gration and Nationality Act or, if applicable, the total 

2 number of immigrant visas that are made available to na3 tives of the country of the aliens’ birth under section 

4 202(e) of such Act. 

5 (e) DENIAL OF PREFERENTIAL IMMIGRATION

6 TREATMENT FOR CERTAIN RELATIVES.—The natural 

7 parents, brothers, and sisters of Mohammed Manir 

8 Hossain, Ferdous Ara Manir, and Maish Samiha Manir 

9 shall not, by virtue of such relationship, be accorded any 

10 right, privilege, or status under the Immigration and Na11 tionality Act. 

Æ
QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.12.3    
    


Amendment No. 10 (the "Amendment") To

Employment Agreement (the "Employment Agreement") between

Ray Rodriguez ("Employee") and The Univision Network Limited Partnership ("Company")  


Employee
and Company agree to amend the Employment Agreement as follows: 


        1.     Term. The Term of the Employment Agreement is extended through December 31, 2006, unless earlier terminated in
accordance with the provisions of the Employment Agreement. 



        2.     Salary. The annual Base Salary rate will be: Eight Hundred Thousand Dollars ($800,000) for the annual period from
January 1, 2006 through December 31, 2006. 


        3.     Effective Date of Amendment. Upon execution by Employee and Company, this Amendment will become effective as of
January 1, 2004. 


        4.     Other. Except as provided in this Amendment, all other terms and conditions in the Employment Agreement will remain in
full force and effect, and the Employment Agreement, as amended hereby, is ratified and confirmed. 



	 	 	THE UNIVISION NETWORK LIMITED PARTNERSHIP
	

 	
 	

By:	
 	

/s/  ROBERT V. CAHILL       
 Robert V. Cahill

Secretary
	

/s/  RAY RODRIGUEZ       
 Ray Rodriguez	
 	

 	
 	

 











QuickLinks



Exhibit 10.12.3
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          AUG-31-1999
<PERIOD-END>                               FEB-28-1999
<CASH>                                          351235
<SECURITIES>                                         0
<RECEIVABLES>                                  2288619
<ALLOWANCES>                                         0
<INVENTORY>                                     602745
<CURRENT-ASSETS>                               3864263
<PP&E>                                         1850314
<DEPRECIATION>                                 1333990
<TOTAL-ASSETS>                                 6856682
<CURRENT-LIABILITIES>                          2957065
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       5831027
<OTHER-SE>                                   (1931410)
<TOTAL-LIABILITY-AND-EQUITY>                   6856682
<SALES>                                        4107844
<TOTAL-REVENUES>                               4110450
<CGS>                                          2111984
<TOTAL-COSTS>                                  3748553
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               27167
<INCOME-PRETAX>                                 334730
<INCOME-TAX>                                      1200
<INCOME-CONTINUING>                             333530
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    333530
<EPS-PRIMARY>                                      .11
<EPS-DILUTED>                                      .11
        

</TABLE>
#### UNIACK, Appellant, v. MERCHANTS' UNION ICE CO., Respondent.

(Supreme Court, Appellate Division, First Department.

June 6, 1913.)

Action by Cornelius Uniack against the Merchants' Union Ice Company. L. F. Fish, of New York City, for appellant. N. Lyon, of New York City, for respondent.

No opinion. Order affirmed, with $10 costs and disbursements. Order filed.
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1657 Introduced in House (IH)]

109th CONGRESS
  1st Session
                                H. R. 1657

 To ensure financial regulations do not harm economic competitiveness, 
nor deprive Americans of due process of law, by repealing provisions of 
  Federal law that hold corporate chief executive officers criminally 
   liable for the content and quality of their companies' financial 
  report, even when the chief executive officers had no intention to 
  engage in criminal behavior, and had taken all reasonable steps to 
                 assure the accuracy of the statement.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 14, 2005

   Mr. Paul introduced the following bill; which was referred to the 
                    Committee on Financial Services

_______________________________________________________________________

                                 A BILL

 
 To ensure financial regulations do not harm economic competitiveness, 
nor deprive Americans of due process of law, by repealing provisions of 
  Federal law that hold corporate chief executive officers criminally 
   liable for the content and quality of their companies' financial 
  report, even when the chief executive officers had no intention to 
  engage in criminal behavior, and had taken all reasonable steps to 
                 assure the accuracy of the statement.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Due Process and Economic 
Competitiveness Restoration Act ''.

SEC. 2. REPEAL.

    Section 404 of the Sarbanes-Oxley Act of 2002 (15 U.S.C. 7262) is 
repealed.
                                 <all>
```
(1)
    
    I have reviewed this quarterly report on Form 10-Q of CHAD Therapeutics, Inc.;(2)
    
    Based on my knowledge, this quarterly report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with respect to the
period covered by this quarterly report;(3)
    
    Based on my knowledge, the financial statements, and other financial information included in
this quarterly report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented
in this quarterly report;(4)
    
    The registrants other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and have:
 (a)
    
    designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during the period in which this
quarterly report is being prepared;(b)
    
    have designed such internal controls to ensure that material information relating
to the issuer and its consolidated subsidiaries is made known to such officers by others
within those entities, particularly during the period in which the periodic reports are
being prepared;(c)
    
    evaluated the effectiveness of the registrants disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such
evaluation; and(d)
    
    disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrants internal control
over financial reporting; and
 (5)
    
    The registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of registrants board of directors (or persons performing the equivalent
functions):
 (a)
    
    all significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information;
and(b)
    
    any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.
 Date: August 14, 2008
    /s/ Tracy A. KernTracy A. KernChief Financial Officer of CHAD Therapeutics, Inc.
Quincy Samuel WEATHERSPOON, petitioner, v. David LONG, Acting Warden.

No. 12-9237.

Supreme Court of the United States

May 20, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
|   | 2002   | 2003   | 2004  | 2005  | 2006 |
|--------|--------|--------|-------|-------|------|
| $1,189 | $1,008 | $1,004 | $990  | $973  |
| 5,430  | 5,311  | 5,078  | 4,514 | 4,476 |
Jerry Baxter GRAVES, petitioner, v. John HOWERTON, Warden.

No. 13-6484.

Supreme Court of the United States

Dec. 2, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
#### WEBB, Respondent, v. LONG ISLAND MUT. FIRE INS. CO., Appellant.

(Supreme *1119Court, Appellate Division, Third Department.

January 11, 1899.)

Action by Robert E. Webb against the Long Island Mutual Eire Insurance Company.

No opinion. Judgment affirmed, with costs.
Jimmy Doyal HINDMAN, petitioner, v. UNITED STATES.

No. 13-7197.

Supreme Court of the United States

Dec. 2, 2013.

Motion of petitioner for leave to proceed *in forma pauperis* denied, and petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit dismissed. See Rule 39.8.

Justice KAGAN took no part in the consideration or decision of this motion and this petition.
[Federal Register Volume 60, Number 103 (Tuesday, May 30, 1995)]
[Notices]
[Pages 28166-28167]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-13149]



-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION
[Investigation No. 731-TA-730 (Preliminary)]


Certain Light-Walled Rectangular Pipe and Tube From Mexico

Determination

    On the basis of the record \1\ developed in the subject 
investigation, the Commission determines, pursuant to section 733(a) of 
the Tariff Act of 1930 (19 U.S.C. 1673b(a)), that there is no 
reasonable indication that an industry in the United States is 
materially injured or threatened with material injury, or that the 
establishment of an industry in the United States is materially 
retarded, by reason of imports from Mexico of certain light-walled 
rectangular pipe and tube,\2\ provided for in subheading 7306.60.50 of 
the Harmonized Tariff Schedule of the United States, that are alleged 
to be sold in the United States at less than fair value (LTFV).

    \1\ The record is defined in Sec. 207.2(f) of the Commission's 
rules of practice and procedure (19 CFR 207.2(f)).
    \2\ The subject products are welded pipes and tubes of nonalloy 
steel, having a wall thickness of less than 4 millimeters (0.156 
inch), of rectangular (including square) cross section. These light-
walled rectangular pipes and tubes are supplied with rectangular 
cross sections ranging from 0.375 x 0.625 inch to 2 x 6 inches or 
with square sections ranging from 0.375 to 4 inches.
---------------------------------------------------------------------------

Background

    On March 31, 1995, a petition was filed with the Commission and the 
Department of Commerce by Southwestern Pipe, Inc., Houston, TX. 
alleging that an industry in the United States is materially injured or 
threatened with material injury by reason of LTFV imports of certain 
light-walled rectangular pipe and tube from Mexico. Accordingly, 
effective March 31, 1995, the Commission instituted antidumping 
investigation No. 731-TA-730 (Preliminary).
    Notice of the institution of the Commission's investigation and of 
a public conference to be held in connection therewith was given by 
posting copies of the notice in the Office of the Secretary, U.S. 
International Trade Commission, Washington, DC, and by publishing the 
notice in the Federal Register of April 11, 1995 (60 FR 18422). The 
conference was held in Washington, DC, on April 21, 1995, and all 
persons who requested the opportunity were permitted to appear in 
person or by counsel.
    The Commission transmitted its determination in this investigation 
to the Secretary of Commerce on May 15, 1995. The views of the 
Commission are contained in USITC Publication 2892 [[Page 28167]] (May 
1995), entitled ``Light-walled rectangular pipe and tube from Mexico: 
Investigation No. 731-TA-730 (Preliminary).''

    Issued: May 23, 1995.

    By order of the Commission.
Donna R. Koehnke,
Secretary.
[FR Doc. 95-13149 Filed 5-26-95; 8:45 am]
BILLING CODE 7020-02-P
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1910 Introduced in House (IH)]

109th CONGRESS
  1st Session
                                H. R. 1910

             To suspend temporarily the duty on Resmethrin.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 27, 2005

Mr. Etheridge introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
             To suspend temporarily the duty on Resmethrin.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. RESMETHRIN.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following:

``      9902.04.42       [5-(Phenylmethyl)- Free         No change        No change        On or before 12/  ''.
                         3-furanyl]methyl                                                   31/2008
                         2,2-dimethyl-3-(2-
                         methyl-1-
                         propenyl)cyclopro
                         panecarboxylate
                         (Resmethrin) (CAS
                         No. 10453-86-8)
                         (provided for in
                         subheading
                         2932.19.10)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
#### ' LAWSON, Appellant, v. LAZANSKY et al., Respondents.

(Supreme Court, Appellate Division, Second Department.

April 4, 1912.)

In the matter of the application of Robert R. Lawson _ against Edward Lazansky and others. No opinion. Order unanimously affirmed, without costs.